Answers are grounded in this paper and cite their sources.
gc/kg in the murine DMD model. This MED served as the starting dose for the RGX-202 clinical study (NCT05693142), which has currently completed phase III enrollment.
No takes yet. Share an insight, caveat, or question.
Owusu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: